Stable non-transforming minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia after autologous transplantation: origin from neoplastic yet ‘pre-leukemic’ stem cells?

PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia

(2010) Gerlinde Mitterbauer et al.   BRITISH JOURNAL OF HAEMATOLOGY

Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion

(2009) Michael Doubek et al.   ANNALS OF HEMATOLOGY

Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL

(2009) S Giebel et al.   BONE MARROW TRANSPLANTATION

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study

(2009) J Familiades et al.   LEUKEMIA

Graft-versus-leukemia effects of transplantation and donor lymphocytes

(2008) H.-J. Kolb   BLOOD

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

(2008) J. J. Cornelissen et al.   BLOOD

Long-term follow-up of a population based cohort with monoclonal proteinaemia

(2008) Cees G. Schaar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors

(2008) Dan Jones et al.   CANCER

Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy

(2008) Ju-Huei Chien et al.   LEUKEMIA RESEARCH

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia

(2008) S. Grammatico et al.   LEUKEMIA RESEARCH

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

(2008) Charles G. Mullighan et al.   NATURE